FDA includes stent grafts in tracking list

08/27/2008 | FDAnews

The FDA has included thoracic aortic aneurysm stent grafts in a list of medical devices that require monitoring, according to a final guidance issued last week. Class II or III devices may be subjected to the FDA's tracking requirements because of various factors, including risk of adverse health effects.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA